Recent Updates
Recently added Catalysts
RDY Positive Sentiment Score: 70/100

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.co

Key Takeaway: Dr. Reddy's Laboratories held a Board Meeting on May 10, 2023, where they reviewed and transacted various business items. The Statutory Auditors provided an Unmodified Opinion on the company's audited financial statements for the year ending March 31, 2023. This indicates a positive audit outcome, reflecting the company's adherence to financial regulations. Details of the Audit Reports have been enclosed in the meeting records.

Market Sentiment Analysis

POSITIVE FACTORS

  • The Board of Directors confirmed an Unmodified Opinion from Statutory Auditors.
  • Successful transacting of business during the Board Meeting.
  • Financial results for the year ended March 31, 2023, were positively acknowledged.

Full Press Release Details

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
of Board Meeting held on May 10, 2023
In furtherance to our letter dated March 23, 2023,
we would like to inform you that the Board of Directors of the Company at its meeting held on May 10, 2023, has, inter alia, transacted
the following businesses:
Pursuant to Regulation 33 of the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015, the Audit Reports of the Statutory Auditors on the financial results
as mentioned at serial nos. 2 & 3 are also enclosed.
We would like to confirm that the Statutory
Auditors of the Company have issued Audit Reports with 'Unmodified Opinion' on the Audited Financial Statements of the Company (Standalone
and Consolidated) for the year ended March 31, 2023.
The Board Meeting commenced at 02:00 PM and concluded
This is for your information and record.
For Dr. Reddy's Laboratories Limited
/s/ K Randhir Singh
K Randhir Singh
Company Secretary, Compliance Officer &

Frequently Asked Questions

When was the Board Meeting held for Dr. Reddy's Laboratories?

The Board Meeting was held on May 10, 2023.

What opinion did the Statutory Auditors issue on the financial statements?

The Statutory Auditors provided an 'Unmodified Opinion' on the financial statements.

What regulations were followed in the audit report disclosure?

The disclosure adhered to Regulation 33 of the SEBI Regulations, 2015.

Who signed the announcement for Dr. Reddy's Laboratories?

The announcement was signed by K Randhir Singh, Company Secretary.

What time did the Board Meeting start and end?

The meeting started at 02:00 PM and concluded thereafter.

Last updated: May 10, 2023